Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

46.22
Delayed Data
As of May 26
 -2.43 / -4.99%
Today’s Change
37.35
Today|||52-Week Range
55.38
+19.43%
Year-to-Date

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 68.00, with a high estimate of 130.00 and a low estimate of 60.00. The median estimate represents a +47.12% increase from the last price of 46.22.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.64
Sales
$2.6M
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.80%
 
 
 
 
 
 
Growthannually -50.10%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 204.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.